UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Cellular physiology and biochemistry, 2018-01, Vol.51 (4), p.1518-1532

2018

Volltextzugriff (PDF)

Clinical significance of estrogen receptor phosphorylation

Endocrine-related cancer, 2011-02, Vol.18 (1), p.R1-R14

2011

Volltextzugriff (PDF)

Claudin 1 expression in basal-like breast cancer is related to patient age

BMC cancer, 2013-05, Vol.13 (1), p.268-268, Article 268

2013

Volltextzugriff (PDF)

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

iScience, 2019-09, Vol.19, p.388-401

2019

Volltextzugriff (PDF)

A robust cell culture system for large scale feeder cell-free expansion of human breast epithelial progenitors

Stem cell research & therapy, 2018-10, Vol.9 (1), p.264-264, Article 264

2018

Volltextzugriff (PDF)

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

The Journal of steroid biochemistry and molecular biology, 2008-03, Vol.109 (1), p.1-10

2008

Volltextzugriff (PDF)

A bi-faceted role of estrogen receptor β in breast cancer

Endocrine-related cancer, 2013-06, Vol.20 (3), p.R127-R139

2013

Volltextzugriff (PDF)

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Endocrine-related cancer, 2006-06, Vol.13 (2), p.327-334

2006

Volltextzugriff (PDF)

Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue

Stem cell reports, 2018-01, Vol.10 (1), p.196-211

2018

Volltextzugriff (PDF)

The role of estrogen receptor-β in breast cancer

Seminars in reproductive medicine, 2012-01, Vol.30 (1), p.5-13

2012

Volltextzugriff (PDF)

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Endocrine-related cancer, 2010-09, Vol.17 (3), p.589-597

2010

Volltextzugriff (PDF)

Recurrent copy number alterations in young women with breast cancer

Oncotarget, 2018-02, Vol.9 (14), p.11541-11558

2018

Volltextzugriff (PDF)

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Cancer letters, 2016-08, Vol.378 (2), p.69-79

2016

Volltextzugriff (PDF)

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

Analytical chemistry (Washington), 2010-07, Vol.82 (13), p.5610-5620

2010

Volltextzugriff (PDF)

S100A7 and the progression of breast cancer

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.153-159, Article 153

2004

Volltextzugriff (PDF)

The Prohibitins: emerging roles in diverse functions

Journal of cellular and molecular medicine, 2006-04, Vol.10 (2), p.353-363

2006

Volltextzugriff (PDF)

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Endocrine-related cancer, 2015-08, Vol.22 (4), p.505-517

2015

Volltextzugriff (PDF)

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

Endocrine-related cancer, 2012-04, Vol.19 (2), p.181-195

2012

Volltextzugriff (PDF)

Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy

Molecular cancer therapeutics, 2014-07, Vol.13 (7), p.1882-1893

2014

Volltextzugriff (PDF)

Lumican and decorin are differentially expressed in human breast carcinoma

The Journal of pathology, 2000-11, Vol.192 (3), p.313-320

2000

Volltextzugriff (PDF)

Prohibitin: a potential target for new therapeutics

Trends in molecular medicine, 2005-04, Vol.11 (4), p.192-197

2005

Volltextzugriff (PDF)

Targeting the EGFR pathway for cancer therapy

Current medicinal chemistry, 2006-12, Vol.13 (29), p.3483-3492

2006

Volltextzugriff (PDF)

Identification of new human coding steroid receptor RNA activator isoforms

Biochemical and biophysical research communications, 2003-02, Vol.301 (2), p.509-515

2003

Volltextzugriff (PDF)

Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factors

Nuclear receptor signaling, 2016, Vol.14 (1), p.e001-e001

2016

Volltextzugriff (PDF)

ERβ splice variant expression in four large cohorts of human breast cancer patient tumors

Breast cancer research and treatment, 2014-08, Vol.146 (3), p.657-667

2014

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Englisch
(189)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(123)
Humans
(117)
Female
(82)
Biological And Medical Sciences
(50)
Animals
(40)
Breast Cancer
(40)
Oncology
(37)
Breast Neoplasms - Metabolism
(36)
Medical Sciences
(33)
Breast Neoplasms - Genetics
(27)
Endocrinology & Metabolism
(26)
Tumors
(26)
Biochemistry & Molecular Biology
(24)
Breast Neoplasms - Pathology
(24)
Middle Aged
(24)
Male
(23)
Cell Biology
(22)
Gene Expression
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Clinical significance of estrogen receptor phosphorylation

Claudin 1 expression in basal-like breast cancer is related to patient age

Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth

A robust cell culture system for large scale feeder cell-free expansion of human breast epithelial progenitors

Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target

A bi-faceted role of estrogen receptor β in breast cancer

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Breast Cancers Activate Stromal Fibroblast-Induced Suppression of Progenitors in Adjacent Normal Tissue

The role of estrogen receptor-β in breast cancer

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Recurrent copy number alterations in young women with breast cancer

Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes

Assay Development for the Determination of Phosphorylation Stoichiometry Using Multiple Reaction Monitoring Methods with and without Phosphatase Treatment: Application to Breast Cancer Signaling Pathways

S100A7 and the progression of breast cancer

The Prohibitins: emerging roles in diverse functions

Estrogen regulates luminal progenitor cell differentiation through H19 gene expression

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy

Lumican and decorin are differentially expressed in human breast carcinoma

Prohibitin: a potential target for new therapeutics

Targeting the EGFR pathway for cancer therapy

Identification of new human coding steroid receptor RNA activator isoforms

Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factors

ERβ splice variant expression in four large cohorts of human breast cancer patient tumors

Aktive Filter

Suchergebnisse filtern